Literature DB >> 1088099

Doxycycline in the treatment of cholera.

S De, A Chaudhuri, P Dutta, D Dutta, S P De, S C Pal.   

Abstract

Doxycycline was compared with tetracycline in the treatment of cholera. Four types of treatment were compared: Group A was given 200 mg of doxycycline on admission and 100 mg on the second day; Group B was given 200 mg of doxycycline on admission only; Group C was given 300 mg of doxycycline on admission only; and Group D received 500 mg of tetracycline every 6 h for 48 h. Tetracycline showed a slight advantage in respect of duration of diarrhoea and vibrio excretion compared with doxycycline given as a single dose of 300 mg, but fluid intake and output were about the same in these two groups. The other two doxycycline treatment schedules did not compare well with tetracycline treatment.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1088099      PMCID: PMC2366441     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  1 in total

1.  Observations on cholera treated orally and intravenously with antibiotics. With particular reference to the number of vibrios excreted in the stool.

Authors:  K Kobari; C Uylangco; J Vasco; Y Takahira; N Shimizu
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

  1 in total
  5 in total

1.  Randomised double blind trial of single dose doxycycline for treating cholera in adults.

Authors:  A N Alam; N H Alam; T Ahmed; D A Sack
Journal:  BMJ       Date:  1990-06-23

Review 2.  Antimicrobial drugs for treating cholera.

Authors:  Ya'ara Leibovici-Weissman; Ami Neuberger; Roni Bitterman; David Sinclair; Mohammed Abdus Salam; Mical Paul
Journal:  Cochrane Database Syst Rev       Date:  2014-06-19

3.  Single-dose doxycycline for cholera.

Authors:  D A Sack; S Islam; H Rabbani; A Islam
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

4.  Single-dose treatment of cholera with furazolidone or tetracycline in a double-blind randomized trial.

Authors:  G H Rabbani; M R Islam; T Butler; M Shahrier; K Alam
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

5.  Guanosine tetra- and pentaphosphate increase antibiotic tolerance by reducing reactive oxygen species production in Vibrio cholerae.

Authors:  Hwa Young Kim; Junhyeok Go; Kang-Mu Lee; Young Taek Oh; Sang Sun Yoon
Journal:  J Biol Chem       Date:  2018-02-23       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.